Immunogenicity and safety of Biological E’s CORBEVAX™ vaccine as a heterologous booster dose in adult volunteers previously vaccinated with two doses of either COVISHIELD™ or COVAXIN: A Prospective double-blind randomised phase III clinical study
bioRxiv (2023) - Comments
doi: 10.1101/2022.12.29.22284049 

Subhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri, Vijay Yerroju, Rammohan Mogulla, Pothakamuri Venkata Suneetha, Kishore Turaga, Akshay Binayke, Aymaan Zaheer, Amit Awasthi, Rashmi Virkar, Manish Narang, Pradeep Nanjappa, Niranjana Mahantshetti, BishanSwarup Garg, Mandal RavindraNath Ravi